Peritoneal and Hemodialysis Show Comparable Survival in ESRD, suggests study

Published On 2025-11-03 14:45 GMT | Update On 2025-11-03 14:45 GMT

A new meta-analysis published in BMC Nephrology reports that there is no significant difference in overall survival between patients undergoing peritoneal dialysis (PD) and those receiving hemodialysis (HD) for end-stage renal disease (ESRD). The study analyzed data from multiple clinical investigations comparing the two dialysis modalities and found that both approaches are equally effective in maintaining patient survival. This suggests that treatment decisions can be tailored based on patient preferences, lifestyle, and clinical suitability rather than concerns about mortality differences.

The researchers noted that while overall survival outcomes were similar, certain subgroups showed slight variations. In particular, patients under the age of 65 appeared to have a lower mortality risk with peritoneal dialysis compared to hemodialysis. Regional factors also seemed to influence outcomes, suggesting that differences in healthcare access, dialysis practices, and socioeconomic conditions may play a role in survival trends. Despite these variations, the results indicate that both PD and HD remain viable and effective long-term renal replacement therapies for ESRD patients.

The findings underscore the importance of individualized treatment planning in kidney care. Healthcare providers are encouraged to evaluate patient-specific factors such as age, comorbidities, and home support systems before selecting the dialysis modality. The study also highlights the need for improved patient education about both types of dialysis to enable shared decision-making. By focusing on patient comfort, adherence, and quality of life, clinicians can ensure optimal outcomes regardless of the dialysis method chosen.

Keywords: peritoneal dialysis, hemodialysis, end-stage renal disease, patient survival, kidney care, renal replacement therapy, BMC Nephrology

Reference: BMC Nephrology. (2025). Peritoneal and hemodialysis show comparable survival in ESRD, suggests study. BioMed Central. https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-025-04530-4Is

Article Source : BMC Nephrology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Shravani Dali

Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Peritoneal and Hemodialysis Show Comparable Survival in ESRD, suggests study

Similar News

Women with Gestational Diabetes Face Greater Chances of Developing Kidney Disease Later in Life: Meta-Analysis

Less can be more: Low-dose steroids could effectively treat severe kidney inflammation, suggests study

SGLT2 Inhibitors Linked to Lower Risk of Kidney Stones in Patients With Type 2 Diabetes: Study Shows

Elevated albumin-corrected anion gap Linked to Increased AKI Risk in Critical acute pancreatitis Patients: Study

FDA Approves Obinutuzumab for Active Lupus Nephritis

Adequate Copper Intake Linked to Lower Risk of Chronic and Diabetic Kidney Disease: NHANES Study

Lowering Albuminuria Improves Survival and Kidney Outcomes in Diabetes-Related CKD: Study